Dallas, TX, July 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NaturalShrimp, Inc. (OTCMKTS: SHMP), announced today that CSIRO Agriculture and Food’s Aquaculture Research Team in Tasmania, Australia (one of the world’s leading aquaculture institutes) has successfully completed Phase-I in vitro testing of a new technology that has proven effective at killing Neoparamoeba perurans, the parasite which causes Amoebic Gill Disease (AGD) of Atlantic salmon. With Phase-I efficacy completed, CSIRO has already received ethics approval for starting Phase-II, which will focus on fish welfare during the experimental treatment.
NaturalShrimp budgets CSIRO’s studies on the generation of AGD through its market position progression along with Hydrenesis, Inc. (Hydrenesis), the exclusive and global market positioning agent for the AGD generation aquaculture market position.
Australia’s national clinical agency, CSIRO (Commonwealth Scientific and Industrial Reseek Organization), is pushing the boundaries of what can be imagined in innovation, science and technology. CSIRO has a global and global influence through collaboration with industry, governments and communities. CSIRO Agriculture and Food adopts a built-in gene technique based on improving crop quality and yield, expanding cutting-edge food processing technologies, creating new value-added foods, and expanding our livestock, aquaculture and fishing industries. https://www.csiro.au/
Hydrenesis President Bob Watson added that “ADGA costs salmon to remove tens of millions of bills a year and we are working with CSIRO and NaturalShrimp to complete testing and start marketing this technology.”
NaturalShrimp CEO Gerald Easterling said: “We are positioning NaturalShrimp as the leading carrier of generation responses in the fish farming industry and the AGD generation of Hydrenesis can change the game for the salmon sector.”
ABOUT NATURALSHRIMP: NaturalShrimp, Inc. is a commercial apple of water technology listed in Dallas, with production services located near San Antonio, Texas. The combined apple developed the first viable formula for the first commercigreatest to prepare shrimp in closed saltwater formulas, employing a patented generation to provide new shrimp, never frozen, naturreatest friends, without antibiotics or toxic chemicals. NaturalShrimp formulas are also found on a large apple around the world to provide gourmet quality Pacific prawns.
Forward-looking statements
This press release includes “forward-looking statements”. Statements contained in this press release that do not appear as an old account are forward-looking statements. Forward-looking statements arise with compabig apple’s current expectations or forecasts in relation to long-term holidays. Such statements are the subject of threats and mismatches that are occasionally more difficult to expect and beyond the control of the Compabig apple, and could also cause the effects of the Compabig apple to differ to the larger friends than described. In some cases, forward search statements may be known through words such as “could,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “”estimates”, and similar expressions. These statements come with statements about the continuation of Apple’s global expansion strategy. Statements are based on current beliefs, expectations, and assumptions, and are subject to one or more threats and mismatches, which are hard to expect. Compabig Apple materializes this wisdom as of the date of this press release and does not undertake to mandatory update Apple’s advanced search statements contained in this press release due to current data, long-term or otherwise parties, unless required by law. We have founded these forward-looking statements on a giant component in our current expectations and projections related to long-term parties and fiscal trends that affect the economic position of our apple. Direct search statements should not be construed as a combination of functionality or long-term effects, and may not necessarily be accurate indications of when or through the functions or effects that can be achieved. The important points that may also cause such differences come, however, do not seem to be limited to the threat points and other data set out in the Compabig Apple Annual Report on Form 10-K filed on June 2, 2019, 201 and nine securities and Exchange filings. Commission.
Contact: Paul Knopick outside pknopick [email protected] 940.262.3584